Balance Study on ICU-acquired Hypernatremia and Sodium Handling (BIAS) (BIAS)

July 17, 2018 updated by: Medical Centre Leeuwarden

Balance Study on ICU-acquired Hypernatremia and Sodium Handling

The goal of this study is to find differences between patients who do and do not develop ICU-acquired hypernatremia (IAH). Therefore extended sodium and fluid balances will be performed. Also a couple of other factors that possibly contribute to the development of IAH and/or could give clues about the mechanisms in the development of IAH will be investigated.

Study Overview

Status

Completed

Detailed Description

ICU-acquired hypernatremia (IAH) is common in critically ill patients, but it's aetiology is still not fully understood. Sodium overload and inadequate fluid administration are generally considered important factors, but a previous retrospective study did not reveal differences in sodium or fluid balances between patients who did and did not develop IAH. Because this was retrospective these balances will be prospectively studied in this study to be more sure about the importances of these balances in the development of IAH. Previous studies indicated that (a lot) more factors contribute to the development of IAH. In this study these factors will be investigated, hoping to find differences between patients who do and do not develop IAH.

Study Type

Observational

Enrollment (Actual)

155

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leeuwarden, Netherlands
        • Medisch Centrum Leeuwarden

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All unplanned ICU-admissions

Description

Inclusion Criteria:

  • Predicted duration of ICU-admission >48 hours

Exclusion Criteria:

  • Renal replacement therapy
  • Reason for admission necessitates actively elevation of serum sodium concentration
  • Electrolyte disturbance as reason for admission
  • ICU re-admission within 30 days
  • Referral from another ICU
  • Serum sodium concentration on admission 143mmol/l or above

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sodium balance
Time Frame: During ICU-admission
Differences in sodium balances between patients who do and do not develop IAH
During ICU-admission
Fluid balance
Time Frame: During ICU-admission
Differences in fluid balances between patients who do and do not develop IAH
During ICU-admission

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kidney function
Time Frame: During ICU-admission
Differences in parameters concerning kidney function (creatinine, urea) between patients who do and do not develop IAH
During ICU-admission
Inflammation
Time Frame: During ICU-admission
Differences in inflammation (CRP, infections) between patients who do and do not develop IAH
During ICU-admission
Nutritional state
Time Frame: During ICU-admission
Differences in nutritional state (albumin, BIVA-measurement) between patients who do and do not develop IAH
During ICU-admission

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christiaan Boerma, Medical Center Leeuwarden

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 7, 2017

Primary Completion (ACTUAL)

April 16, 2018

Study Completion (ACTUAL)

June 1, 2018

Study Registration Dates

First Submitted

March 22, 2017

First Submitted That Met QC Criteria

March 27, 2017

First Posted (ACTUAL)

March 28, 2017

Study Record Updates

Last Update Posted (ACTUAL)

July 18, 2018

Last Update Submitted That Met QC Criteria

July 17, 2018

Last Verified

May 1, 2017

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ZRTPO 996

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Collected data will be available through an online portal / storage website as soon as the manuscript was published. From that moment data can be obtained after a request via the online portal / storage website.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ICU-acquired Hypernatremia

3
Subscribe